Application of Generative Artificial Intelligence in Perioperative Personalized Rehabilitation for Older Adults With Lung Cancer
NCT07915193, Not applicable, Enrolling by invitation, Peking University Cancer Hospital & Institute
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Application of Generative Artificial Intelligence in Perioperative Personalized Rehabilitation for Older Adults With Lung Cancer | ClinicalTrials.gov |
| NCT number | NCT07915193 | ClinicalTrials.gov |
| Status | Enrolling by invitation | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 150 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Peking University Cancer Hospital & Institute | ClinicalTrials.gov |
| Conditions | Lung Neoplasms | ClinicalTrials.gov |
| Interventions | AI-guided personalized rehabilitation | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | MDASI-LC quality-of-life scores | Before surgery; 1 week and 2 weeks after hospital discharge; and at the 1-month postoperative return visit | Quality of life will be assessed using the MD Anderson Symptom Inventory for Lung Cancer (MDASI-LC), including 6 items on symptom interference with daily life and 16 items measuring symptom severity. The scores will be collected using an online questionnaire. | ClinicalTrials.gov |
| Primary | Forced Expiratory Volume in 1 Second (FEV1) | Before surgery, on the day of hospital discharge, and at the 1-month postoperative return visit | FEV1 will be measured using a handheld spirometer. | ClinicalTrials.gov |
| Primary | Forced Vital Capacity (FVC) | Before surgery; on the day of hospital discharge; and at the 1-month postoperative return visit. | FVC will be measured using a handheld spirometer. | ClinicalTrials.gov |
| Primary | Maximum Voluntary Ventilation (MVV) | Before surgery; on the day of hospital discharge; and at the 1-month postoperative return visit. | MVV will be measured using a handheld spirometer. | ClinicalTrials.gov |
| Secondary | Borg Rating of Perceived Exertion During Aerobic Exercise | Before surgery and at postoperative weeks 1, 2, 3, and 4. | Perceived exertion during aerobic exercise will be assessed using the Borg Rating of Perceived Exertion (RPE) Scale. Scores range from 6 to 20, with higher scores indicating greater perceived exertion. | ClinicalTrials.gov |
| Secondary | Emergency Department Visits | From randomization through 24 months after surgery. | 'The number of participants with an emergency department visit will be recorded. | ClinicalTrials.gov |
| Secondary | Hospital Readmissions | From randomization through 24 months after surgery. | The number of participants readmitted to the hospital will be recorded. | ClinicalTrials.gov |
| Secondary | Adverse Events Related to the AI-Based Rehabilitation System | From first use of the system through 24 months after surgery. | The number of participants experiencing adverse events related to use of the system will be recorded, including injuries associated with excessive exercise, falls, eye strain, or other harm related to system use. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)